FDA Panel Backs New COVID Booster Focusing Only on Variants

The committee voted 21-0 that a new vaccine should focus on just one strain of the virus, and not be a bivalent shot as before. Any new vaccine should target one of three now prevalent in the U.S.: XBB.1.5, XBB.1.16 and XBB.2.3.